A carregar...

EGFR/HER-targeted therapeutics in ovarian cancer

Despite decades of research and evolving treatment modalities, survival among patients with epithelial ovarian cancer has improved only incrementally. During this same period, the development of biologically targeted therapeutics has improved survival for patients with diverse malignancies. Many of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Future Med Chem
Main Authors: Wilken, Jason A, Badri, Tayf, Cross, Sarah, Raji, Rhoda, Santin, Alessandro D, Schwartz, Peter, Branscum, Adam J, Baron, Andre T, Sakhitab, Adam I, Maihle, Nita J
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4620931/
https://ncbi.nlm.nih.gov/pubmed/22416774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fmc.12.11
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!